In Brief: ICH carcinogenicity guideline
ICH carcinogenicity guideline: International Conference on Harmonization draft guideline on "testing for carcinogenicity of pharmaceuticals" is published in the Aug. 21 Federal Register and designates a 60-day written comment period. The draft outlines experimental approaches for evaluating the carcinogenic potential of pharmaceuticals to humans "that may obviate the necessity for the routine conduct of two long-term rodent carcinogenicity studies"...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth